These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 12928377)
1. CpG DNA induces a class II transactivator-independent increase in class II MHC by stabilizing class II MHC mRNA in B lymphocytes. Kuchtey J; Pennini M; Pai RK; Harding CV J Immunol; 2003 Sep; 171(5):2320-5. PubMed ID: 12928377 [TBL] [Abstract][Full Text] [Related]
2. CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms. Askew D; Chu RS; Krieg AM; Harding CV J Immunol; 2000 Dec; 165(12):6889-95. PubMed ID: 11120813 [TBL] [Abstract][Full Text] [Related]
3. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease. Stüve O; Youssef S; Slavin AJ; King CL; Patarroyo JC; Hirschberg DL; Brickey WJ; Soos JM; Piskurich JF; Chapman HA; Zamvil SS J Immunol; 2002 Dec; 169(12):6720-32. PubMed ID: 12471103 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of dendritic cell antigen cross-presentation by CpG DNA involves type I IFN and stabilization of class I MHC mRNA. Kuchtey J; Chefalo PJ; Gray RC; Ramachandra L; Harding CV J Immunol; 2005 Aug; 175(4):2244-51. PubMed ID: 16081792 [TBL] [Abstract][Full Text] [Related]
5. Nitric oxide inhibits INFgamma-induced increases in CIITA mRNA abundance and activation of CIITA dependent genes--class II MHC, Ii and H-2M. Class II TransActivator. Kielar ML; Sicher SC; Penfield JG; Jeyarajah DR; Lu CY Inflammation; 2000 Oct; 24(5):431-45. PubMed ID: 10921507 [TBL] [Abstract][Full Text] [Related]
7. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain. Itoh-Lindstrom Y; Piskurich JF; Felix NJ; Wang Y; Brickey WJ; Platt JL; Koller BH; Ting JP J Immunol; 1999 Sep; 163(5):2425-31. PubMed ID: 10452977 [TBL] [Abstract][Full Text] [Related]
8. Enhanced production of IL-10 by dendritic cells deficient in CIITA. Yee CS; Yao Y; Xu Q; McCarthy B; Sun-Lin D; Tone M; Waldmann H; Chang CH J Immunol; 2005 Feb; 174(3):1222-9. PubMed ID: 15661876 [TBL] [Abstract][Full Text] [Related]
10. Regulation of class II MHC expression in APCs: roles of types I, III, and IV class II transactivator. Pai RK; Askew D; Boom WH; Harding CV J Immunol; 2002 Aug; 169(3):1326-33. PubMed ID: 12133955 [TBL] [Abstract][Full Text] [Related]
11. Regulation of the class II MHC pathway in primary human monocytes by granulocyte-macrophage colony-stimulating factor. Hornell TM; Beresford GW; Bushey A; Boss JM; Mellins ED J Immunol; 2003 Sep; 171(5):2374-83. PubMed ID: 12928384 [TBL] [Abstract][Full Text] [Related]
12. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene. Rohn W; Tang LP; Dong Y; Benveniste EN J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. Pai RK; Convery M; Hamilton TA; Boom WH; Harding CV J Immunol; 2003 Jul; 171(1):175-84. PubMed ID: 12816996 [TBL] [Abstract][Full Text] [Related]
14. Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing. Simmons DP; Wearsch PA; Canaday DH; Meyerson HJ; Liu YC; Wang Y; Boom WH; Harding CV J Immunol; 2012 Apr; 188(7):3116-26. PubMed ID: 22371391 [TBL] [Abstract][Full Text] [Related]
15. IFN-gamma-induced MHC class II expression: transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-alpha. Giroux M; Schmidt M; Descoteaux A J Immunol; 2003 Oct; 171(8):4187-94. PubMed ID: 14530341 [TBL] [Abstract][Full Text] [Related]
16. Mycobacterium tuberculosis heat shock fusion protein enhances class I MHC cross-processing and -presentation by B lymphocytes. Tobian AA; Harding CV; Canaday DH J Immunol; 2005 May; 174(9):5209-14. PubMed ID: 15843516 [TBL] [Abstract][Full Text] [Related]
17. Control of in vitro immune responses by regulatory oligodeoxynucleotides through inhibition of pIII promoter directed expression of MHC class II transactivator in human primary monocytes. Wang J; Roderiquez G; Jones T; McPhie P; Norcross MA J Immunol; 2007 Jul; 179(1):45-52. PubMed ID: 17579020 [TBL] [Abstract][Full Text] [Related]
18. The MHC class II transactivator (CIITA) mRNA stability is critical for the HLA class II gene expression in myelomonocytic cells. De Lerma Barbaro A; Procopio FA; Mortara L; Tosi G; Accolla RS Eur J Immunol; 2005 Feb; 35(2):603-11. PubMed ID: 15627980 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation. Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831 [TBL] [Abstract][Full Text] [Related]
20. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes. Villard J; Muhlethaler-Mottet A; Bontron S; Mach B; Reith W Int Immunol; 1999 Mar; 11(3):461-9. PubMed ID: 10221658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]